Metasphere Labs Inc.
LABZF
$0.13
$0.0333.53%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -99.89% | -99.93% | -90.27% | -48.07% | 31.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -99.89% | -99.93% | -90.27% | -48.07% | 31.26% |
| Cost of Revenue | -99.36% | -99.54% | -85.65% | -36.49% | 23.93% |
| Gross Profit | -99.99% | -99.99% | -91.11% | -50.27% | 32.84% |
| SG&A Expenses | -43.59% | -27.01% | -15.74% | -8.72% | -68.10% |
| Depreciation & Amortization | -- | -- | -62.11% | -47.13% | -61.89% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -57.21% | -47.64% | -32.53% | -14.49% | -62.15% |
| Operating Income | -1,174.48% | -221.65% | -211.85% | -580.47% | 102.15% |
| Income Before Tax | -17.84% | -31,109.52% | -347.94% | 64.12% | 93.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.84% | -31,109.52% | -347.94% | 64.12% | 93.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.84% | -31,109.52% | -405.11% | 64.05% | 94.02% |
| EBIT | -1,174.48% | -221.65% | -211.85% | -580.47% | 102.15% |
| EBITDA | -536.58% | -206.16% | -193.94% | -333.57% | 104.65% |
| EPS Basic | -182.95% | -114.77% | 89.00% | 98.10% | 99.89% |
| Normalized Basic EPS | -284.00% | -113.06% | -160.91% | 93.46% | 100.48% |
| EPS Diluted | -23.96% | -119.05% | 88.34% | 98.05% | 99.69% |
| Normalized Diluted EPS | -420.75% | -114.05% | -182.05% | 93.41% | 99.83% |
| Average Basic Shares Outstanding | 33.53% | 79.03% | 143.85% | 554.19% | 1,520.89% |
| Average Diluted Shares Outstanding | 8.26% | 35.18% | 65.22% | 364.18% | 1,899.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |